Built on science. Strengthened by trust.
Glytec is at the forefront of evidence-based innovation proven by data, guided by science, and focused on outcomes. That impact is amplified through the trust of healthcare leaders, industry partners, and independent evaluators.
From national recognitions to strategic collaborations, we’re proud of the confidence others place in our technology and our mission to advance safe, effective glycemic management.
MedTech Breakthrough
Best Computerized Decision Support Solution
Glytec is honored to be recognized by MedTech Breakthrough as the Best Computerized Decision Support Solution. This award underscores Glytec’s leadership in clinical decision support technology and highlights the proven impact of our FDA-cleared technology platform. By guiding safe, personalized insulin therapy, Glytec helps hospitals reduce preventable harm from poor glucose control and advance safer, more effective patient care.
Stevie Awards for Technology Excellence
Gold Stevie® Award in the Healthcare Technology Solution category
This award recognized Glytec for its industry-leading work in inpatient diabetes and insulin management. The Stevie Awards for Technology Excellence recognize the remarkable achievements of individuals, teams, and organizations that are shaping the future of technology across all industry sectors.
Georgia Hospital Association (GHA)
Glytec is proud to partner with the Georgia Hospital Association (GHA) through its exclusive Sponsorship Program. This collaboration enables us to support GHA’s mission of advancing quality care and operational excellence across Georgia’s hospitals, while building meaningful relationships with healthcare leaders and decision makers. Together, we’re working to drive safer, more efficient glycemic management statewide.
Texas Hospital Association (THA)
Glytec is honored to partner with the Texas Hospital Association (THA) to support hospitals across the state in navigating today’s evolving healthcare landscape. Through THA’s trusted platform, we connect with hospital leaders committed to improving clinical outcomes, streamlining operations, and enhancing patient safety. Our partnership reflects a shared dedication to delivering proven, cost-effective solutions for insulin management and glycemic care.
Leapfrog Group
Glytec is proud to serve on The Leapfrog Group’s Partner Advisory Committee, supporting its mission to improve patient safety and hospital transparency nationwide. As a member of this collaborative network, we contribute insights on safe, effective glycemic management and align with industry leaders to drive measurable improvements in care quality. Our partnership underscores a shared commitment to reducing harm and advancing clinical excellence.
Roche
Collaboration with Roche supports data integration and real-time clinical decision-making—key for personalized, effective glycemic management. Together, this partnership bridges diagnostics with insulin dosing support, optimizing care across inpatient settings.
Hospital Association of San Diego & Imperial Counties
Glytec is honored to be an Associate Member of Hospital Association of San Diego & Imperial Counties (HASD&IC) – supportive of association activities and programs and aligned with HASD&IC’s purpose to help member hospitals provide high quality health care and to improve the health status of the communities they serve.




